UNSPSC 51162713: Guaiacol

This classification denotes an anti-infective agent and expectorant with the molecular formula C7H8O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 6JKA7MAH9C, chemically known as phenol, o-methoxy- but more generally known as guaiacol, which bears US NIH Compound Identifier 460. European Medicines Agency schedules Guaiacol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14027MIG. Most nations, for tariff and trade purposes, schedule guaiacol under HS 29095000 and SITC 51617.

As of Q4 2014, GUAIACOL remains US FDA's Preferred Term for this commodity. Guaiacol bears US NLM identifiers UMLS ID C0018304 and NCI Concept Code C76663. SMILES: O(C1C(O)CCCC1)C.

UNSPSC 51162713 Guaiacol (Commodity) is a chemical compound used in pharmaceutical and medical applications, but recent state and local solicitations tagged with this code show little alignment with guaiacol itself. The Washington State Department of Corrections RFQ RFQQK13020, due October 7, 2026, solicits parenteral products, services, and equipment — including total parenteral nutrition solutions, intravenous solutions, and other injectable healthcare products for eight correctional facilities. Seminole County, Florida's IFB 60459723LAS (due July 26, 2023) seeks naloxone and drug deactivation systems for community health distribution. Both opportunities involve pharmaceutical or medical supply procurement by state and local health and corrections agencies, but neither represents guaiacol procurement directly. The issuing bodies span state corrections departments and county health authorities, suggesting the code may be misapplied to broader parenteral and pharmaceutical categories rather than guaiacol-specific procurement.

Geographic activity appears concentrated in the Pacific Northwest and Florida based on the two named solicitations. The Washington State Department of Corrections opportunity represents the more recent and detailed posting, with service spanning three regional groups of correctional facilities across Washington state and contract awards anticipated through June 2030. Contractors must meet Washington State licensure, insurance, and background-clearance requirements, with pricing fixed for the initial two-year term and delivery windows of 24 hours for specialized nutrition preparations and 8 hours for standard parenteral products. The Seminole County opportunity, though dated, emphasizes quarterly distribution logistics to a specific community health location with fixed-fee pricing and a two-year initial term. The code shows limited recent state and local activity, and the mismatch between the guaiacol commodity definition and the parenteral-product and naloxone-focused solicitations suggests procurement professionals should verify coding accuracy before pursuing opportunities tagged under this classification.